Outcomes Study: Identifying Barriers to Treatment with Psychiatric Medications Among People Who Are Incarcerated

All Posts

Outcomes Study: Identifying Barriers to Treatment with Psychiatric Medications Among People Who Are Incarcerated

Background

  • 9-20% of the 2.3 million people in U.S. jails and prisons have a serious mental illness
  • Wilper et al. found that 26.3% of federal inmates, 28.9% of state inmates, and 41.8% of jail inmates were not continued on home medications while incarcerated
  • Lack of access to mental health medications can lead to decompensation, disciplinary action from correctional staff, increased victimization from other inmates, and placement in solitary confinement
  • Lack of access can also result in admission to state mental health facilities to restore competency which requires continued medication access upon return to jail
  • Studies have noted that jails often lack resources for appropriate medication management, psychosocial assessments, and crisis intervention
  • While there have been studies on resources and treatment barriers for inmates, there is a lack of information focused specifically on medications

Objectives

Primary Objective

Characterize the barriers to receiving psychiatric medications for people who are incarcerated

Secondary Objectives

  • Compare the barriers to receiving psychiatric medications for people who are incarcerated before competency restoration to after competency restoration
  • Characterize psychiatric medication formularies of jails

 

Read the Outcomes Study by submitting the form below.

Related Posts

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.